In our aging society, with an increased urgency to develop new compounds that target serious illnesses like Alzheimer's and Parkinson's disease, memory enhancement drugs are becoming a big business. But these same drugs are also creating a growing ethical controversy over their potential off-label uses, such as taking these drugs as "performance enhancers" to gain a competitive advantage in the workplace. These issues, along with the biochemistry of memory, are explored in a recent article.
Memory Enhancement Drugs Show Promise But Face Growing Scrutiny
- ScienceDaily
- 3. 9 2007 (06:00)